Navigation Links
WebMD to Present at the Morgan Stanley Technology Conference
Date:2/27/2009

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD) and HLTH Corporation (Nasdaq: HLTH) today announced that executives of WebMD are scheduled to participate at the Morgan Stanley Technology Conference on Tuesday, March 3, 2009 at 7:05 p.m. ET.

Investors, analysts and the general public are invited to listen to a live audio broadcast of the presentation over the Internet. The broadcast can be accessed at www.wbmd.com (in the Investor Relations section). A replay of the broadcast will be available at the same web address.

About WebMD

WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. WebMD Health Corp. is a subsidiary of HLTH Corporation (Nasdaq: HLTH).

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements are based on WebMD's current plans and expectations and involve risks and uncertainties, including those described in our SEC filings.


'/>"/>
SOURCE WebMD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. WebMD to Present at the Goldman Sachs Technology and Internet Conference
2. WebMD Announces Fourth Quarter Financial Results
3. HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call
4. WebMD to Present at the 27th Annual J.P. Morgan Healthcare Conference
5. WebMD Announces Repurchase of 640,930 of its Shares
6. HLTH Corporation and WebMD to Webcast Annual Meetings of Stockholders
7. WebMD and Marketing Technology Solutions Terminate Merger Agreement
8. WebMD Announces 2008 Health Heroes
9. WebMD Highlights Presidential Candidates Views on Health Care
10. GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle
11. WebMD to Present at the William Blair 28th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Franklin, TN (PRWEB) , ... May 26, 2016 , ... ... today, and more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, ... the 29th annual National Cancer Survivors Day®. , National Cancer Survivors Day® is ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the ... users and those who do not use the app. Dr. Mohebi, the founder of Parsa ... Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat ...
(Date:5/26/2016)... Texas (PRWEB) , ... May 26, 2016 , ... ... Friday, May 13 at Blackhorse Golf Club in Cypress. With the help of community ... non-profit that restores, empowers, and renews hope for wounded service members and their families ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading ... PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power ... the 8 hour interactive course to qualify participants as certified PowerWave trainers. ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our ... PROTECTION TO YOUR HEAD ™”. , “We are proud to introduce Meghan ... football front we have Brian Quick, wide receiver for Los Angeles who was a ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)...   , ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung ... plus guter , Reinigung des ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... von der MORA-Studie der Phase III für NER1006 ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology: